Riluzole promotes neurological function recovery and inhibits damage extension in rats following spinal cord injury: a meta-analysis and systematic review

Journal of Neurochemistry
Long-Yun ZhouYong-Jun Wang

Abstract

Spinal cord injury (SCI) is a devastating condition that has few treatment options. Riluzole, a sodium channel blocker used to treat amyotrophic lateral sclerosis, has been initially trialed in human SCI. We performed a systematic review to critically assess the efficacy of riluzole in locomotor recovery and damage extension in SCI rat models, and the potential for clinical translation. PubMed, Embase, Cochrane Library, and Chinese databases were searched from their inception date to March 2018. Two reviewers independently selected animal studies that evaluated neurological recovery and lesion area following riluzole treatment in SCI rat models, extracted data and assessed methodological quality. Pairwise meta-analysis, subgroup analysis, and network meta-analysis were performed to assess the effects of riluzole on SCI. Ten eligible studies were included. Two studies had high methodological quality. Overall, the Basso, Beattie, and Bresnahan scores were increased in riluzole-treated animals versus controls, and effect sizes showed a gradual increase from the 1st (five studies, n = 104, mean difference = 1.24, 95% CI = 0.11 to 2.37, p = 0.03) to 6th week after treatment (five studies, n = 120, mean difference = 2.34, 95% CI = 1....Continue Reading

References

Jan 1, 1978·Equine Veterinary Journal·A R Moorthy, P B Spradbrow
Feb 1, 1995·Journal of Neurotrauma·D M BassoJ C Bresnahan
Jan 31, 1996·Neuroreport·J M StutzmannC Gross
Dec 9, 1997·Clinical Pharmacology and Therapeutics·R BrunoG R Rhodes
Aug 5, 2000·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·L Lang-LazdunskiM Lazdunski
Oct 13, 2000·The European Journal of Neuroscience·A Urbani, O Belluzzi
Mar 15, 2002·Journal of Neurotrauma·Aubrey A Webb, Gillian D Muir
Jun 14, 2002·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·L LacomblezUNKNOWN ALS Study Groups I and II
Jan 28, 2005·Journal of Neurotrauma·Alun AckeryAndrei Krassioukov
Jul 22, 2006·Lancet Neurology·Volker Dietz, Armin Curt
May 29, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Ozkan AtesAyhan Kocak
Dec 19, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Manuel D GalvanAileen J Anderson
Feb 28, 2009·Stroke; a Journal of Cerebral Circulation·Marc FisherUNKNOWN STAIR Group
May 12, 2009·Neuroscience Letters·Alison StevensonChristopher C J Miller
Oct 20, 2010·Journal of Neurotrauma·Aldric Hama, Jacqueline Sagen
Dec 20, 2011·Experimental Neurology·J Marc SimardVolodymyr Gerzanich
Sep 19, 2012·Journal of Neurosurgery. Spine·Diana S L ChowRobert G Grossman
Aug 1, 2010·Evidence-based Spine-care Journal·Yongchao WuMichael G Fehlings
Jul 10, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Bareket DanielArie Gruzman
May 6, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Narihito NagoshiMichael G Fehlings
Jun 10, 2015·JAMA : the Journal of the American Medical Association·Nitin B JainEric Garshick
Sep 24, 2015·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Laureen D HachemCharles H Tator

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Lancet
D J Reynolds
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
D F Gelinas
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Narihito NagoshiMichael G Fehlings
© 2022 Meta ULC. All rights reserved